Back
Aquestive Therapeutics Vs. Supernus Pharmaceuticals Industry Stock Comparison
Buy
63
AQST
Aquestive Therapeutics
Last Price:
5.20
Seasonality Move:
11.7%
Sell
25
SUPN
Supernus Pharmaceuticals
Last Price:
32.11
Seasonality Move:
-9.35%
Buy
63
Aquestive Therapeutics (AQST)
is a Buy
Is Aquestive Therapeutics a Buy, Sell or Hold?
- The current Aquestive Therapeutics [AQST] share price is $4.95. The Score for AQST is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
- AQST is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
25
Supernus Pharmaceuticals (SUPN)
is a Sell
Is Supernus Pharmaceuticals a Buy, Sell or Hold?
- The current Supernus Pharmaceuticals [SUPN] share price is $31.84. The Score for SUPN is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
- SUPN is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
AQST Stock Price Chart
What is Aquestive Therapeutics's stock price today?
-
The Aquestive Therapeutics share price today is $4.95
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AQST is experiencing buying pressure, which is a positive indicator for future bullish movement.
SUPN Stock Price Chart
What is Supernus Pharmaceuticals's stock price today?
-
The Supernus Pharmaceuticals share price today is $31.84
The current trend is relatively stagnant and SUPN is experiencing slight buying pressure.
AQST Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.27 | Buy |
Relative Strength Index (14 RSI): | 61.82 | Buy |
Chaikin Money Flow: | 96799 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
SUPN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.2 | Sell |
Relative Strength Index (14 RSI): | 43.28 | Sell |
Chaikin Money Flow: | -131766 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
AQST Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 4.79 | Buy |
20-day SMA: | 4.56 | Buy |
50-day SMA: | 3.89 | Buy |
200-day SMA: | 3.32 | Buy |
8-day EMA: | 4.76 | Buy |
20-day EMA: | 4.52 | Buy |
50-day EMA: | 4.05 | Buy |
200-day EMA: | 3.28 | Buy |
SUPN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 31.94 | Sell |
20-day SMA: | 33.61 | Sell |
50-day SMA: | 31.83 | Buy |
200-day SMA: | 29.75 | Buy |
8-day EMA: | 32.09 | Sell |
20-day EMA: | 32.72 | Sell |
50-day EMA: | 31.89 | Sell |
200-day EMA: | 30.33 | Buy |
Aquestive Therapeutics Earnings Growth & AQST Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.01 per share, a decrease this year of $0.11 per share, and a decrease next year of $0.12 per share.
Supernus Pharmaceuticals Earnings Growth & SUPN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.36 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.02 per share, and a decrease next year of $0.18 per share.
Aquestive Therapeutics Technical Analysis
Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Supernus Pharmaceuticals Technical Analysis
Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |